// App-Quantinova.ai

PO1577 : STAGED-PKD: An Enriched, Seamless, Two-Stage Study for Venglustat Assessment in ADPKD

Researchers

Presenter

  • Perrone RonaldD

Principal Investigators

  • Hariri Ali

  • Minini Pascal

  • Ahn Curie

  • Chapman ArleneB

  • Horie Shigeo

  • Knebelmann Bertrand

  • Mrug Michal

  • Ong AlbertC

  • Pei YorkP

  • Torres VicenteE

  • Modur Vijay

  • Gansevoort RonT

Medical Centers

  • Division of Nephrology Tufts Medical Center Tufts University School of Medicine Boston Massachusetts United States

  • Sanofi Genzyme, Massachusetts, United States

  • Sanofi, Chilly-Mazarin, France

  • Department of Internal Medicine, Seoul National University Bundang Hospital, Seongnam, Korea, Republic of (South)

  • Department of Medicine,The University of Chicago,Chicago,United States

  • Department of Hematology, Kumamoto University School of Medicine, Kumamoto, Japan

  • Université Paris-Descartes Faculté de Médecine AP-HP Service de Néphrologie Hôpital Necker-Enfants Malades Paris France

  • Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, United States

  • Infection, Immunity & Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom,

  • Division of Nephrology University of Toronto Toronto Ontario Canada

  • Mayo Translational Polycystic Kidney Disease Center Mayo Clinic Rochester Minnesota United States

  • Department of Medical Oncology, University Medical Center Groningen, Groningen, Netherlands

Locations

  • United States

  • France

  • Japan

  • United Kingdom

  • Canada

  • Netherlands

Companies

  • N/A

Study Components

Therapeutic Area

  • Nephrology

  • Genetic Disorder

Disease

  • Autosomal dominant polycystic kidney disease

Biomarkers

  • Tissue factor pathway inhibitor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Double Blind/Blinded

  • Multinational

  • Controlled

Phase

  • II/III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved